Navigation Links
Cardium Reports on Fourth Quarter and Year-End 2009 Financial Results and Recent Developments
Date:3/16/2010

- (977,051) - (6) - (6) --------- --------- ------- --------- Net Income (loss) $9,316,127 $(5,077,953) $(1,261,631) $(3,301,085) ========== =========== =========== =========== Net income (loss) per common share – basic and diluted $0.17 $(0.11) $(0.02) $(0.07) ===== ====== ====== ====== Weighted average common shares outstanding – basic 54,207,761 46,930,439 54,207,761 46,930,439 Weighted average common shares outstanding – diluted 54,374,522 46,930,439 54,374,522 46,930,439 The Year Ended December 31, -------------------------------------------------------- Pro forma Pro forma Audited Audited Results Results 2009 2008 2009* 2008* ---- ---- ----- ----- Revenues $444,946 $416,912 $444,946 $416,912 --------- --------- ------- --------- Research and development (4,302,298) (11,041,930) (3,633,251)(1) (9,965,058)(1) General and administrative (4,855,582) (6,529,346) (4,615,487)(1) (5,623,029)(1) --------- --------- --------- --------- Loss from operations (9,157,880) (17,571,276) (8,248,738) (15,588,087) --------- ---------- --------- ---------- Interest income (expense), net (6,327,363) (447,626) (1,025,036)(8) (13,365)(8) Change in fair value
'/>"/>
SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine technology :

1. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
4. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
7. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
8. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
9. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
10. Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development
11. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 2014  Sanguine Biosciences – a biotechnology company ... recruitment – will use its proprietary mobile application ... Inc. find and recruit people diagnosed with Congenital ... to participate in voluntary research, which will be ... hopefully aid in informing the development of potential ...
(Date:11/18/2014)... , Nov. 18, 2014  TransCelerate BioPharma ... most recent manuscript on Risk-Based Monitoring (RBM), ... Quality Control Measure in Clinical Trials ," ... Innovation & Regulatory Science  (TIRS) journal. Developed ... with Medidata, the manuscript examines the value ...
(Date:11/18/2014)... SOUTH EASTON, Mass. , Nov. 18, 2014 ... or the "Company") today announced the installation of ... for independent evaluation and subsequent potential sale. One ... Radoslav Goldman of Georgetown University while ... a leading biotechnology company. In both settings, the ...
Breaking Medicine Technology:Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3Pressure BioSciences Ships First Two Barozyme HT48 Systems 2Pressure BioSciences Ships First Two Barozyme HT48 Systems 3Pressure BioSciences Ships First Two Barozyme HT48 Systems 4Pressure BioSciences Ships First Two Barozyme HT48 Systems 5
(Date:11/18/2014)... November 18, 2014 Global ... using the telehealth platform to bring quality healthcare ... this passion, GPT created Global Partnership for TeleHealth ... already existing telehealth network. GPTM focuses specifically ... overseas, and disaster relief organizations. , ...
(Date:11/18/2014)... Sorrel Sky Gallery welcomes jewelry artist and ... her beautiful, one-of-a-kind pieces. Just in time for the holidays, ... Friday, December 5 from 5 – 7:30 p.m. for the ... creations began at her grandmother’s kitchen table at a very ... She studied at the Gemological Institute of America in California ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... low-dose aspirin therapy may not have significant heart-health benefits ... study, which involved more than 14,000 Japanese people aged ... deaths or non-fatal heart attacks and strokes between people ... "It indicates that primary prevention with daily low-dose aspirin ...
(Date:11/18/2014)... HealthDay Reporter MONDAY, Nov. 17, ... that help them track how many calories they consume each ... a popular one after their doctor recommended it did not ... idea of using such apps as weight-loss tools. Some participants ... of motivation varied, the researchers noted, and they added that ...
(Date:11/17/2014)... 2014 QuickChek customers and employees demonstrated ... “Dog Tag” Promotion. In total, the New Jersey ... Warriors® in support of military families both locally and ... nonprofit dedicated to restoring a sense of self, restoring ... members and our military families. , Throughout the ...
Breaking Medicine News(10 mins):Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2Health News:Elizabeth Showers Trunk Show & Personal Appearance Hosted by Sorrel Sky Gallery 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Calorie-Tracking Apps May Not Help You Lose Weight 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 3Health News:QuickChek Gives Big Support to Hope For The Warriors One Dollar at a Time 2
... presentations on ZEVALIN(R) scheduled at American Society of Hematology ... ... Inc.,(CTI) (Nasdaq: CTIC ; MTAX) today announced it intends to ... (Ibritumomab,Tiuxetan), known as the FIT trial, for submission to the United ...
... relationship between infection outbreaks on teeth and the presence of ... which has an unknown origin. Alopecia areata starts with bald ... The disease occurs in males and females of all ages, ... , Research by professors Jos Antonio Gil Montoya and Antonio ...
... Dec. 6, 2007 to Address FDA,s Next Big Challenge, ... Information on Drugs and Devices to Physicians and the ... banned the,use of a device that repairs damaged cells ... Magnetic Inductor (PAP-IMI),because of its apparent connection to patient ...
... 26 /PRNewswire-FirstCall/ - The Westaim Corporation,announced today that it ... of its,holdings in Canadian third party asset-backed commercial paper ... proceeds of $6.0 million.,Westaim retains the right to receive ... ABCP within six months; in such event, Westaim,will receive ...
... SINGAPORE, Nov. 26 Flextronics (Nasdaq: FLEX ),today ... Tuesday,January 29, 2008., The earnings conference call, hosted ... PST to discuss the financial results,of the Company for ... earnings call will be available via the Internet and ...
... suggests , MONDAY, Nov. 26 (HealthDay News) -- Non-white women ... linked to metastatic breast cancer, according to a study looking ... women -- all with metastatic breast cancer and bone metastases ... Inventory repeatedly over one year. The test uses a scale ...
Cached Medicine News:Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 2Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 3Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 4Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 5Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 6Health News:Infection outbreaks on teeth can cause 'alopecia areata' or localized hair loss 2Health News:Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information 2Health News:Westaim reduces ABCP exposure 2Health News:Flextronics to Report Third Quarter Results 2